Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) Depreciation & Amortization - Total (2017 - 2025)

HealthLynked (HLYK) has disclosed Depreciation & Amortization - Total for 8 consecutive years, with $26454.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization - Total fell 6.97% to $26454.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $101871.0 through Dec 2025, down 11.5% year-over-year, with the annual reading at $101871.0 for FY2025, 11.5% down from the prior year.
  • Depreciation & Amortization - Total for Q4 2025 was $26454.0 at HealthLynked, up from $20155.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization - Total was $31253.0 in Q2 2023, with the low at $20155.0 in Q3 2025.
  • Average Depreciation & Amortization - Total over 5 years is $28278.8, with a median of $28322.0 recorded in 2022.
  • The sharpest move saw Depreciation & Amortization - Total grew 20.57% in 2021, then dropped 27.15% in 2025.
  • Over 5 years, Depreciation & Amortization - Total stood at $25291.0 in 2021, then grew by 11.53% to $28208.0 in 2022, then rose by 10.7% to $31226.0 in 2023, then dropped by 8.93% to $28436.0 in 2024, then dropped by 6.97% to $26454.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization - Total over the past three periods came in at $26454.0, $20155.0, and $27238.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.